Madeleine Roy

1.2k total citations
24 papers, 910 citations indexed

About

Madeleine Roy is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Madeleine Roy has authored 24 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Molecular Biology. Recurrent topics in Madeleine Roy's work include Lipoproteins and Cardiovascular Health (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Madeleine Roy is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Madeleine Roy collaborates with scholars based in Canada, United States and Spain. Madeleine Roy's co-authors include André Barbeau, S. Paris, Jean Davignon, T. Cloutier, Judes Poirier, J. Davignon, G Campanella, Jeffrey S. Cohn, David S. Rosenblatt and Anne Minnich and has published in prestigious journals such as The Lancet, Neurology and Annals of Neurology.

In The Last Decade

Madeleine Roy

23 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Madeleine Roy Canada 15 327 290 192 184 177 24 910
Joanna Kosacka Germany 20 117 0.4× 88 0.3× 151 0.8× 285 1.5× 86 0.5× 39 968
Masanori Sawamura Japan 15 103 0.3× 116 0.4× 112 0.6× 547 3.0× 114 0.6× 57 1.1k
Fumihiko Yonemori Japan 13 41 0.1× 451 1.6× 163 0.8× 307 1.7× 339 1.9× 23 989
Patricia Sullivan United States 14 255 0.8× 168 0.6× 186 1.0× 129 0.7× 144 0.8× 21 719
Ping Zheng China 10 84 0.3× 82 0.3× 104 0.5× 388 2.1× 57 0.3× 18 925
N. Koh Japan 13 87 0.3× 75 0.3× 48 0.3× 261 1.4× 141 0.8× 26 705
Gökhan S. Hotamisligil United States 11 83 0.3× 61 0.2× 85 0.4× 373 2.0× 64 0.4× 11 838
Y Ihara Japan 8 94 0.3× 271 0.9× 104 0.5× 368 2.0× 255 1.4× 9 878
Toshitaka Nakagawa Japan 17 63 0.2× 48 0.2× 67 0.3× 184 1.0× 128 0.7× 38 738
K Okamoto Japan 9 71 0.2× 79 0.3× 103 0.5× 208 1.1× 138 0.8× 22 813

Countries citing papers authored by Madeleine Roy

Since Specialization
Citations

This map shows the geographic impact of Madeleine Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madeleine Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madeleine Roy more than expected).

Fields of papers citing papers by Madeleine Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madeleine Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madeleine Roy. The network helps show where Madeleine Roy may publish in the future.

Co-authorship network of co-authors of Madeleine Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Madeleine Roy. A scholar is included among the top collaborators of Madeleine Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madeleine Roy. Madeleine Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cohn, Jeffrey S., Lucie Boulet, Hélène Jacques, et al.. (2003). Plasma concentration and lipoprotein distribution of ApoC-I is dependent on ApoE genotype rather than the Hpa I ApoC-I promoter polymorphism. Atherosclerosis. 169(1). 63–70. 22 indexed citations
3.
Cohn, Jeffrey S., Michel J. Tremblay, Hélène Jacques, et al.. (2002). Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia. Journal of Lipid Research. 43(9). 1464–1471. 22 indexed citations
4.
Carmena, Rafael, Madeleine Roy, Ghislaine O. Roederer, Anne Minnich, & J. Davignon. (2000). Coexisting dysbetalipoproteinemia and familial hypercholesterolemia. Atherosclerosis. 148(1). 113–124. 22 indexed citations
5.
Grewal, Thomas, Mathieu Boudreau, Madeleine Roy, et al.. (1998). Expression of γ-IFN responsive genes in scavenger receptor over-expressing monocytes is associated with xanthomatosis. Atherosclerosis. 138(2). 335–345. 6 indexed citations
6.
Vohl, Marie‐Claude, Madeleine Roy, Daniel Gaudet, et al.. (1997). Geographic distribution of French‐Canadian low‐density lipoprotein receptor gene mutations in the Province of Quebec. Clinical Genetics. 52(1). 1–6. 35 indexed citations
7.
Richter, Andréa, Josée Poirier, Jocelyne Mercier, et al.. (1996). Friedreich ataxia in Acadian families from eastern Canada: Clinical diversity with conserved haplotypes. American Journal of Medical Genetics. 64(4). 594–601. 23 indexed citations
8.
Carmena, Rafael, Suzanne Lussier‐Cacan, Madeleine Roy, et al.. (1996). Lp(a) Levels and Atherosclerotic Vascular Disease in a Sample of Patients With Familial Hypercholesterolemia Sharing the Same Gene Defect. Arteriosclerosis Thrombosis and Vascular Biology. 16(1). 129–136. 41 indexed citations
9.
Cohn, Jeffrey S., Michel J. Tremblay, D Bouthillier, et al.. (1996). Plasma Concentration of Apolipoprotein E in Intermediate-Sized Remnant-Like Lipoproteins in Normolipidemic and Hyperlipidemic Subjects. Arteriosclerosis Thrombosis and Vascular Biology. 16(1). 149–159. 87 indexed citations
10.
Sass, Catherine, Yuanhong Ma, Madeleine Roy, et al.. (1995). Evidence for a cholesterol-lowering gene in a French-Canadian kindred with familial hypercholesterolemia. Human Genetics. 96(1). 21–26. 14 indexed citations
11.
Minnich, Anne, et al.. (1995). New methods for rapid detection of low-density lipoprotein receptor and apolipoprotein B gene mutations causing familial hypercholesterolemia. Clinical Biochemistry. 28(3). 277–284. 12 indexed citations
12.
Roy, Madeleine, Charles F. Sing, Christine Bétard, & Jean Davignon. (1995). Impact of a common mutation of the LDL receptor gene, in French‐Canadian patients with familial hypercholesterolemia, on means, variances and correlations among traits of lipid metabolism. Clinical Genetics. 47(2). 59–67. 14 indexed citations
13.
Davignon, J. & Madeleine Roy. (1993). Familial hypercholesterolemia in French-Canadians: Taking advantage of the presence of a “founder effect”. The American Journal of Cardiology. 72(10). D6–D10. 38 indexed citations
14.
Bharadwaj, Dwaipayan, et al.. (1992). Pyroglutamate aminopeptidase in rat submaxillary gland.. PubMed. 29(5). 442–4. 1 indexed citations
15.
Davignon, Jean, Jean Dallongeville, Ghislaine O. Roederer, et al.. (1991). A Phenocopy of Type III Dysbetalipoproteinemia Occurring in a Candidate Family for a Putative Apo E Receptor Defect. Annals of Medicine. 23(2). 161–167. 5 indexed citations
16.
Ma, Yuanhong, Christine Bétard, Madeleine Roy, Jean Davignon, & Anna M. Kessling. (1989). Identification of a second “French Canadian” LDL receptor gene deletion and development of a rapid method to detect both deletions. Clinical Genetics. 36(4). 219–228. 59 indexed citations
17.
Barbeau, André, et al.. (1987). Ecogenetics of Parkinson's Disease: Prevalence and Environmental Aspects in Rural Areas. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 14(1). 36–41. 124 indexed citations
18.
Barbeau, André, Madeleine Roy, & T. Cloutier. (1986). Smoking, cancer, and Parkinson's disease. Annals of Neurology. 20(1). 105–106. 6 indexed citations
19.
Barbeau, André, et al.. (1985). ECOGENETICS OF PARKINSON'S DISEASE: 4-HYDROXYLATION OF DEBRISOQUINE. The Lancet. 326(8466). 1213–1216. 174 indexed citations
20.
Barbeau, André & Madeleine Roy. (1976). Six‐year results of treatment with levodopa plus benzerazide in Parkinson's disease. Neurology. 26(5). 399–399. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026